Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- RGS.AU
- Price
- -
- Stock movement up
- +- (%)
- Company name
- Regeneus Ltd
- Exchange
- (AU ,
- Currency
- AUD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 2.76M
- Ent value
- 4.15M
- Price/Sales
- 57.18
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -25.00%
- 3 year return
- -58.40%
- 5 year return
- -41.11%
- 10 year return
- -
Last updated: 2024-12-17
DIVIDENDS
RGS.AU does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 57.18 |
| Price to Book | - |
| EV to Sales | 86.12 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 306.44M |
| EPS (TTM) | -0.03 |
| FCF per share (TTM) | -0.01 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 48.23K |
| Gross profit (TTM) | 48.23K |
| Operating income (TTM) | -9.33M |
| Net income (TTM) | -9.43M |
| EPS (TTM) | -0.03 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 100.00% |
| Operating margin (TTM) | -19344.64% |
| Profit margin (TTM) | -19559.59% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 1.03M |
| Net receivables | 0.00 |
| Total current assets | 1.35M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 1.36M |
| Accounts payable | 0.00 |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 2.42M |
| Total liabilities | 2.42M |
| Shareholder's equity | -1.06M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -2.57M |
| Capital expenditures (TTM) | 12.70K |
| Free cash flow (TTM) | -2.59M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | -694.43% |
| Return on Invested Capital | -1007.36% |
| Cash Return on Invested Capital | -276.20% |
STOCK INFORMATION
Downside potential
Loading...
Downside potential data
| RGS.AU | S&P500 | |
| Current price drop from All-time high | -98.47% | -2.51% |
| Highest price drop | -99.49% | -56.47% |
| Date of highest drop | 5 Jan 2024 | 9 Mar 2009 |
| Avg drop from high | -77.77% | -11.07% |
| Avg time to new high | 157 days | 12 days |
| Max time to new high | 2463 days | 1805 days |
COMPANY DETAILS
Marketcap
2.76M
Marketcap category
Small-cap
Description
Regeneus Ltd, a clinical stage regenerative medicine company, develops cell-based therapies for the human health markets with a focus on osteoarthritis and other musculoskeletal disorders, neuropathic pain, and dermatology diseases in Australia. Its lead platform technology includes Progenza, a multi-synergistic therapy for the treatment of osteoarthritis and neuropathic pain. The company also develops Sygenus for the treatment of skin wound healing. Regeneus Ltd was incorporated in 2007 and is headquartered in Paddington, Australia.
Employees
0
Website
Investor relations
-
SEC filings
CEO
Country
Australia
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found